Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMiD) drug and an anti-CD38 monoclonal antibody...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.78 | -1.24620546413 | 62.59 | 64.71 | 60.93 | 257482 | 62.61345823 | CS |
4 | 7.35 | 13.4961439589 | 54.46 | 67.37 | 53 | 400487 | 61.78066837 | CS |
12 | 9.56 | 18.2966507177 | 52.25 | 67.37 | 47.88 | 450358 | 55.63951106 | CS |
26 | -0.55 | -0.881975625401 | 62.36 | 75.1 | 47.88 | 451606 | 59.44298256 | CS |
52 | 27.69 | 81.1547479484 | 34.12 | 75.1 | 30.88 | 520958 | 51.06271573 | CS |
156 | 42.81 | 225.315789474 | 19 | 75.1 | 6.035 | 469830 | 37.86846047 | CS |
260 | 42.81 | 225.315789474 | 19 | 75.1 | 6.035 | 469830 | 37.86846047 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約